---
// src/pages/science/transport.astro
import BaseLayout from "../../layouts/BaseLayout.astro";
import { useTranslations } from "../../i18n";

const t = useTranslations('en');
---

<BaseLayout 
  title={t.sections.transport.title}
  description="Neuronal transport mechanisms: how substances travel from peripheral nerves to the spinal cord via retrograde axonal transport."
>
  <section class="bg-gradient-to-b from-slate-900 to-slate-800 text-white py-16">
    <div class="max-w-7xl mx-auto px-4 sm:px-6 lg:px-8">
      <nav class="text-sm text-slate-400 mb-4">
        <a href="/" class="hover:text-white transition-colors">Home</a>
        <span class="mx-2">/</span>
        <a href="/science/" class="hover:text-white transition-colors">Science</a>
        <span class="mx-2">/</span>
        <span class="text-white">Neuronal Transport</span>
      </nav>
      <h1 class="text-4xl md:text-5xl font-bold mb-4">{t.sections.transport.title}</h1>
      <p class="text-xl text-slate-300 max-w-3xl">
        {t.sections.transport.subtitle}
      </p>
    </div>
  </section>

  <section class="py-12">
    <div class="max-w-4xl mx-auto px-4 sm:px-6 lg:px-8">
      <div class="prose-science">
        
        <h2>Retrograde Axonal Transport</h2>
        <p>
          Neurons maintain bidirectional transport systems along their axons. Retrograde transport 
          moves cargo from the axon terminal toward the cell body, powered by dynein motor proteins. 
          This system is essential for:
        </p>
        <ul>
          <li>Returning neurotransmitter receptors for recycling</li>
          <li>Transporting neurotrophic factors (e.g., NGF) to the soma</li>
          <li>Signaling endosome trafficking</li>
        </ul>
        <p>
          Unfortunately, the same transport machinery can be hijacked by pathogens and toxins.
        </p>

        <h2>Tetanus Toxin as a Model</h2>
        <p>
          Tetanus toxin provides the paradigm for understanding how GT1b-binding molecules reach 
          the CNS:
        </p>
        <ol>
          <li><strong>Binding:</strong> The heavy chain C-terminus (Hc) binds GT1b ganglioside on nerve terminals</li>
          <li><strong>Internalization:</strong> Receptor-mediated endocytosis brings the toxin inside</li>
          <li><strong>Transport:</strong> Signaling endosomes carry the toxin retrograde toward the soma</li>
          <li><strong>Release:</strong> Unlike cholera toxin, tetanus toxin is released into the spinal cord parenchyma</li>
        </ol>

        <div class="key-concept">
          <div class="key-concept-title">Critical Observation</div>
          <p class="mb-0">
            My unpublished research showed that tetanus toxin fragments were released extraneuronally 
            in the spinal cord, while cholera toxin B-subunit remained confined within nerve terminals. 
            This difference may be crucial for understanding how vaccine antigens could trigger 
            autoimmune responses in the CNS.
          </p>
        </div>

        <h2>Intraneuronal vs. Perineuronal Injection</h2>
        <p>
          The efficiency of retrograde transport depends critically on delivery method:
        </p>
        
        <div class="grid md:grid-cols-2 gap-6 my-8">
          <div class="bg-emerald-50 border border-emerald-200 rounded-lg p-4">
            <h4 class="font-bold text-emerald-800 mb-2">Intraneuronal Injection</h4>
            <ul class="text-sm text-emerald-700 space-y-1">
              <li>• Direct deposition within nerve fascicle</li>
              <li>• Highly efficient uptake</li>
              <li>• Minimal loss to surrounding tissue</li>
              <li>• Reliable transport to spinal cord</li>
            </ul>
          </div>
          <div class="bg-slate-50 border border-slate-200 rounded-lg p-4">
            <h4 class="font-bold text-slate-800 mb-2">Perineuronal Application</h4>
            <ul class="text-sm text-slate-700 space-y-1">
              <li>• Application near but not inside nerve</li>
              <li>• Poor uptake efficiency</li>
              <li>• Dilution in surrounding tissue</li>
              <li>• Unreliable transport</li>
            </ul>
          </div>
        </div>

        <p>
          This distinction is crucial: standard intramuscular vaccination rarely results in nerve 
          penetration, but when it does occur (particularly in the deltoid region near the 
          axillary nerve), the transport efficiency is dramatically higher.
        </p>

        <h2>The Axillary Nerve</h2>
        <p>
          The axillary nerve courses through the deltoid region where vaccinations are administered. 
          Its anatomy creates vulnerability:
        </p>
        <ul>
          <li>Passes through the quadrilateral space below the shoulder joint</li>
          <li>Lies relatively superficial in parts of its course</li>
          <li>Individual anatomical variation affects depth</li>
          <li>Thin patients may have nerves closer to the injection zone</li>
        </ul>

        <h2>Lamina I: The Critical Convergence Zone</h2>
        <p>
          Primary afferent neurons from peripheral nerves terminate in specific layers (laminae) 
          of the spinal cord dorsal horn. Lamina I (the marginal zone) receives:
        </p>
        <ul>
          <li>Nociceptive afferents (pain fibers)</li>
          <li>Thermoreceptive afferents (temperature)</li>
          <li>C-fiber inputs from various peripheral tissues</li>
        </ul>

        <div class="key-concept">
          <div class="key-concept-title">Descending Orexinergic Projections</div>
          <p class="mb-2">
            Critically, <strong>orexin neurons project from hypothalamus to Lamina I</strong>. 
            Immunohistochemical studies show dense orexin-immunoreactive fibers at all spinal levels.
          </p>
          <ul class="mb-0 text-sm">
            <li>• Orexin-A fibers <strong>co-localize with Substance P</strong> (primary sensory neuron marker)</li>
            <li>• <strong>Bidirectional transport</strong> proven: OX1R travels anterograde from DRG; OXA accumulates retrograde toward DRG</li>
            <li>• This creates a direct <strong>PNS-CNS molecular exchange route</strong></li>
          </ul>
        </div>

        <h2>The "Peripheral Entry" Hypothesis</h2>
        <p>
          This anatomical arrangement suggests an alternative pathway for narcolepsy pathogenesis:
        </p>

        <figure class="my-8">
          <img 
            src="/images/peripheral-entry-pathway.svg" 
            alt="Peripheral Entry Hypothesis: H1N1 antigen transport from injection site to hypothalamus via spinal cord"
            class="w-full rounded-lg border border-slate-200 shadow-lg bg-white"
          />
          <figcaption class="text-sm text-slate-600 mt-3 text-center">
            <strong>The Peripheral Entry Hypothesis:</strong> Vaccine antigen binds GT1b on peripheral nerve terminals, 
            is transported retrograde to Lamina I, where it encounters orexin afferents. The resulting immune response 
            causes "dying back" degeneration to the hypothalamus.
          </figcaption>
        </figure>

        <h3>Step-by-Step Mechanism</h3>
        <ol>
          <li><strong>Injection & Binding:</strong> H1N1-HA in Pandemrix binds GT1b ganglioside on nerve terminals in deltoid muscle</li>
          <li><strong>AS03 Potentiation:</strong> The lipid adjuvant enhances membrane permeability and endocytosis</li>
          <li><strong>Retrograde Transport:</strong> Antigen-containing endosomes are carried by dynein motors along the axon</li>
          <li><strong>DRG Transit:</strong> The complex passes through dorsal root ganglion cell bodies</li>
          <li><strong>Lamina I Release:</strong> Unlike cholera toxin (which stays intraneuronal), H1N1 antigen is <em>released extraneuronally</em></li>
          <li><strong>Immune Activation:</strong> Released antigen triggers local inflammation, activating microglia</li>
          <li><strong>Cross-Reactivity:</strong> T-cells activated against H1N1 peptides cross-react with orexin epitopes</li>
          <li><strong>"Dying Back":</strong> Damage to orexin terminals in Lamina I propagates retrograde to hypothalamus</li>
        </ol>

        <div class="warning-box">
          <h4 class="font-bold text-amber-800 mb-2">The Anatomical Coincidence</h4>
          <p class="text-amber-700 text-sm mb-0">
            The convergence of peripheral nerve afferents and orexin-containing afferents in 
            Lamina I creates an anatomical substrate for autoimmune cross-reactivity. Vaccine 
            antigens deposited in this zone would be optimally positioned to trigger immune 
            responses against orexin neurons. This explains why a <em>peripheral</em> injection 
            causes <em>central</em> neurodegeneration.
          </p>
        </div>

        <h2>H1N1 Hemagglutinin and GT1b Binding</h2>
        <p>
          For the peripheral entry hypothesis to work, H1N1 must bind GT1b with sufficient affinity:
        </p>
        
        <div class="bg-blue-50 border border-blue-200 rounded-lg p-6 my-6">
          <h4 class="font-bold text-blue-800 mb-4">Evidence for H1N1-GT1b Interaction</h4>
          <ul class="text-blue-700 space-y-2">
            <li>• Multiple studies show H1N1 binds gangliosides from human tissue, including GT1b</li>
            <li>• GT1b contains both α2-3 and α2-8 linked sialic acids — multiple binding sites for viral proteins</li>
            <li>• GT1b is the primary receptor for Merkel Cell Polyomavirus — confirming its capacity for viral binding</li>
            <li>• Tetanus toxin uses GT1b/GD1b for neuroinvasion — the transport machinery exists</li>
          </ul>
        </div>

        <h3>The Anti-GM3 Antibody Paradox</h3>
        <p>
          Children with Pandemrix-associated NT1 show elevated <strong>anti-GM3 antibodies</strong>, not anti-GT1b. 
          This doesn't contradict the GT1b hypothesis:
        </p>
        <ul>
          <li><strong>Degradation pathway:</strong> GT1b → GD1b → GM1 → GM3 (via neuraminidases)</li>
          <li><strong>Epitope exposure:</strong> When GT1b is processed by immune cells, sialic acids are cleaved, exposing GM3</li>
          <li><strong>Immunogenicity:</strong> GM3 may be more immunogenic once "unmasked" during inflammation</li>
        </ul>
        <p>
          Thus, <strong>anti-GM3 is the "smoke" while GT1b was the "fuel"</strong> that enabled transport.
        </p>

        <h2>Clinical Correlations</h2>
        
        <h3>Spinal Inflammation in Acute NT1</h3>
        <p>
          If the spinal cord is involved in pathogenesis, we should see evidence of spinal inflammation:
        </p>
        <ul>
          <li><strong>CSF Pleocytosis:</strong> Elevated white blood cells in cerebrospinal fluid have been observed in acute-onset NT1</li>
          <li><strong>Timing:</strong> This inflammation is often transient — visible only if lumbar puncture is done early</li>
          <li><strong>Interpretation:</strong> Consistent with acute myelitis that resolves once neurons have died</li>
        </ul>

        <h3>Sensory Symptoms in NT1</h3>
        <p>
          Since Lamina I modulates pain perception, spinal involvement should cause sensory symptoms:
        </p>
        <ul>
          <li>Many NT1 patients report <strong>chronic pain, paresthesias, and altered pain thresholds</strong></li>
          <li>These are often attributed to sleep disruption, but may reflect direct Lamina I damage</li>
          <li>Dysfunction of descending pain-inhibitory orexin pathways could explain these symptoms</li>
        </ul>

        <div class="info-box">
          <h4 class="font-bold text-blue-800 mb-2">Research Implications</h4>
          <p class="text-blue-700 text-sm mb-0">
            If the peripheral entry hypothesis is correct, prevention strategies should focus on 
            <strong>minimizing nerve exposure during vaccination</strong> (e.g., injection technique, needle length) 
            and <strong>identifying individuals with elevated GT1b expression</strong> (via B3GALT4 genotyping) 
            for personalized vaccine protocols.
          </p>
        </div>
      </div>
    </div>
  </section>
</BaseLayout>
